Quantcast

Latest research Stories

2014-09-18 23:05:40

MarketOptimizer.org adds “Edema Global Clinical Trials Review, H2, 2014” to its store. This report provides elemental information and data relating to the clinical trials on Edema. Dallas, Texas (PRWEB) September 18, 2014 Clinical trial report, “Edema Global Clinical Trials Review, H2, 2014″ provides data on the Edema clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Edema. It includes an overview of the trial numbers...

2014-09-18 12:30:02

Liz Moench, President & CEO of MediciGroup® Inc., will Chair the Allan Lloyds Patient Recruitment and Retention Summit Asia-Emerging Markets, 2014 PHILADELPHIA and LONDON, Sept. 18, 2014 /PRNewswire/ -- It's a new era for biopharmaceutical companies. Competition for innovation, increasing clinical development costs, new technologies and a necessity to keep up with the fast-changing environment are important factors driving industry change. These factors also influence clinical trials, and...

2014-09-18 12:29:26

PLYMOUTH MEETING, Pa., Sept. 18, 2014 /PRNewswire/ -- ePharmaSolutions, the leading provider of eClinical trial solutions, was recognized as the Disruptive Innovator of the Year at Dpharm 2014 for its ePharmaONE cloud-based eClinical platform. This solution includes an integrated clinical trial portal and electronic trial master file (eTMF), a remote monitoring application, eSource and electronic informed-consent solution, and ePharmaSolutions' ReferralPlus+ patient screening and...

2014-09-18 08:30:24

FDA Removes Clinical Hold on Phase 2 Clinical Trial SAN DIEGO, Sept. 18, 2014 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced that the U.S. Food and Drug Administration (FDA) has removed the clinical hold on patient enrollment and dosing of PEGPH20 in SWOG's ongoing Phase 1b/2 clinical trial (S1313). The trial is designed to evaluate Halozyme's investigational drug PEGPH20 (PEGylated Recombinant Human Hyaluronidase) in combination with modified FOLFIRINOX...

2014-09-18 08:29:10

Drug Development Team Now Complete and Fully Focused on Clinical Trial Implementation NEW YORK, Sept. 18, 2014 /PRNewswire/ -- Relmada Therapeutics, Inc., (OTCQB: RLMD), a clinical-stage company developing novel therapies for the treatment of chronic pain, announced today that it has appointed Mr. Christopher W. James to the position of Senior Director of Clinical Development. During his extensive career in Clinical Research, Mr. James has established and led successful global...

2014-09-18 08:20:30

PLYMOUTH MEETING, Pa., Sept. 18, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NASDAQ: INO) announced today CEO Dr. J. Joseph Kim will be presenting at two upcoming investor conferences in New York, NY: Biocentury's NewsMakers in the Biotech Industry Conference and Bernstein's Genes as Drugs Event. NewsMakers in the Biotech IndustrySeptember 26, 20142:30 PM ETInvestor Presentation Bernstein's Genes as DrugsOctober 7, 20141:00 PM ETThis presentation will not be webcasted....

2014-09-17 23:13:48

Leading life sciences and healthcare technology consultancy, d-Wise, takes an active leadership role in PhUSE Annual Conference on clinical trial data transparency. Morrisville, NC (PRWEB) September 17, 2014 d-Wise, a global technology consulting company focused on the life sciences and healthcare industries, will be leading four different presentations at the PhUSE 10th anniversary conference, which is focused on clinical trial data transparency. This industry-leading conference will be...

2014-09-17 12:27:03

-- Compass(TM) Up for Technology Innovation Award -- NEWTOWN, Pa., Sept. 17, 2014 /PRNewswire/ -- BioClinica®, Inc., a leading provider of outsourced clinical trial services and eClinical Solutions, today announced three of its experts are speaking at the 20th Annual SCDM Conference for Clinical Data Management to be held September 28 to October 1 in Las Vegas, Nevada. The Company also announced the innovative Compass technology, a risk-based monitoring solution to raise overall quality in...

2014-09-16 23:15:45

Seattle’s own Cancer Research And Biostatistics (CRAB), and Translational Drug Development (TD2) in Scottsdale, would like to jointly announce CRAB’s assumption of responsibility for the PCRT, a world-renowned consortium comprised of a team of pancreatic cancer experts committed to improve treatment outcomes for patients with this deadly cancer. Seattle, WA (PRWEB) September 16, 2014 Seattle’s own Cancer Research And Biostatistics (CRAB), and Translational Drug Development (TD2) in...

2014-09-16 23:12:55

The research team at Avail Clinical is conducting a clinical study to evaluate a new remedy for the common cold. Adults who are experiencing early cold symptoms, but are otherwise healthy, may qualify to participate. DeLand, Florida (PRWEB) September 16, 2014 *Anyone who is interested in learning more about the clinical trials being conducted in DeLand, FL can visit Avail Clinical Research on the web (http://www.availclinical.com/trial/common-cold/) or contact them directly at (386)...


Word of the Day
abrosia
  • Wasting away as a result of abstinence from food.
The word 'abrosia' comes from a Greek roots meaning 'not' and 'eating'.